Mammary gland involution provides a unique model to study the TGF-β cancer paradox

作者: Qiuchen Guo , Courtney Betts , Nathan Pennock , Elizabeth Mitchell , Pepper Schedin

DOI: 10.3390/JCM6010010

关键词:

摘要: Transforming Growth Factor-β (TGF-β) signaling in cancer has been termed the “TGF-β paradox”, acting as both a tumor suppresser and promoter. The complexity of TGF-β within is context dependent, greatly impacted by cellular crosstalk between responsive cells microenvironment including adjacent epithelial, endothelial, mesenchymal, hematopoietic cells. Here we utilize normal, weaning-induced mammary gland involution tissue model to study function. This article reviews facets that are regulated, namely epithelial cell death, immune activation, extracellular matrix remodeling. We outline how distinct responses types during physiologically normal contribute simultaneous suppressive promotional microenvironments. also highlight alternatives direct blocking anti-cancer therapies with an emphasis on eliciting concerted microenvironmental-mediated suppression.

参考文章(126)
Thomas Doetschman, Gregory P. Boivin, Peter S. Gartside, Sandra J. Engle, Ilona Ormsby, James B. Hoying, Transforming Growth Factor β1 Suppresses Nonmetastatic Colon Cancer at an Early Stage of Tumorigenesis Cancer Research. ,vol. 59, pp. 3379- 3386 ,(1999)
J Fornetti, K C Flanders, P M Henson, A-C Tan, V F Borges, P Schedin, Mammary epithelial cell phagocytosis downstream of TGF-β3 is characterized by adherens junction reorganization Cell Death & Differentiation. ,vol. 23, pp. 185- 196 ,(2016) , 10.1038/CDD.2015.82
Ian A. Darby, Tim D. Hewitson, Fibroblast Differentiation in Wound Healing and Fibrosis International Review of Cytology-a Survey of Cell Biology. ,vol. 257, pp. 143- 179 ,(2007) , 10.1016/S0074-7696(07)57004-X
M C Birchenall-Roberts, F W Ruscetti, O S Bang, T Fu, J M Turley, J J Kasper, T Francomano, L A Falk, Transforming growth factor beta 1 functions in monocytic differentiation of hematopoietic cells through autocrine and paracrine mechanisms Cell Growth & Differentiation. ,vol. 7, pp. 1535- 1544 ,(1996)
J. P. Annes, Making sense of latent TGFβ activation Journal of Cell Science. ,vol. 116, pp. 217- 224 ,(2003) , 10.1242/JCS.00229
Michael Lahn, Stephan Herbertz, J. Scott Sawyer, Anja J Stauber, Ivelina Gueorguieva, Kyla E Driscoll, Shawn T Estrem, Ann L Cleverly, Durisala Desaiah, Susan C Guba, Karim A Benhadji, Christopher A Slapak, Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway Drug Design Development and Therapy. ,vol. 9, pp. 4479- 4499 ,(2015) , 10.2147/DDDT.S86621
G. Giaccone, L.A. Bazhenova, J. Nemunaitis, M. Tan, E. Juhász, R. Ramlau, M.M. van den Heuvel, R. Lal, G.H Kloecker, K.D. Eaton, Q. Chu, D.J. Dunlop, M. Jain, E.B. Garon, C.S. Davis, E. Carrier, S.C. Moses, D.L. Shawler, H. Fakhrai, A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer. European Journal of Cancer. ,vol. 51, pp. 2321- 2329 ,(2015) , 10.1016/J.EJCA.2015.07.035
Jian Xu, Samy Lamouille, Rik Derynck, TGF-beta-induced epithelial to mesenchymal transition. Cell Research. ,vol. 19, pp. 156- 172 ,(2009) , 10.1038/CR.2009.5